Green G M, Jakab G J, Low R B, Davis G S
Am Rev Respir Dis. 1977 Mar;115(3):479-514. doi: 10.1164/arrd.1977.115.3.479.
The success or failure of pulmonary defense mechanisms largely determines the appearance of clinical lung disease. The lung is protected by interlucking systems of nonspecific and specific defenses. Inhaled substrances can be isolated by mechanical barriers or can be physically removed from the lung either by transport up the bronchial mucociliary escalator or by transport through interstitial and lymphatic channels leading to lymph nodes. Substances can be locally detoxified within the lung by interaction with secretory proteins, such as antibodies, or by neutralization and dissolution within phagocytic cells. The pulmonary alveolar macrophage is the central figure in the protection of the respiratory membrane, operating in all 3 of the nonspecific modes of defense and augmented by specific immunologic mechanisms as well. Alterations in macrophage function and physiology may be crucial in determining the effectiveness of pulmonary defense. Recent advances in the cell biology of the alveolar macrophage have led to a greater understanding of its complex funcition. The multiple origins of macrophages from local and circulating cell pools and the variability in their fate and lifespan reflect the multi-faceted role of this cell type. The importance of the interactions between macrophages, orther lung cells, and other defense mechanisms has become increasingly clear. As well as functioning as resident defender of the alveolus, the macrophage is an important effector of the pulmonary immune response and plays a key role in the pathogenesis of a wide variety of inflammatory, destructive, and fibrotic lung diseases. Humoral and cell-mediated immune responses amplify and direct lung defenses against infection and may also participate in protection against other agents. Immunoglobulin A and G, microbial neutralizing and opsonizing anti-bodies, and macrophage-stimulating T lymphocytes are the major immunospecific forms of lung defense. Infectious agents, cigarette smoke, air pollutants, industrial dusts, and a spectrum of coexistent disease states may impair pulmonary defense mechanisms and increase susceptibility to asute and chronic respiratory diseases. A thorough understanding of the ways in which the lung protects itself against the daily assault of infectious, toxic, and immunogenic materials should lead to a beter understanding of pathogenesis and consequences of lung disease and to better clinical care of the patient with respiratory disease.
肺部防御机制的成败在很大程度上决定了临床肺部疾病的表现。肺由非特异性和特异性防御相互交织的系统保护着。吸入的物质可通过机械屏障隔离,或通过支气管黏液纤毛转运系统向上转运,或通过通向淋巴结的间质和淋巴通道从肺中物理清除。物质可通过与分泌蛋白(如抗体)相互作用在肺内进行局部解毒,或在吞噬细胞内被中和及溶解。肺泡巨噬细胞是保护呼吸膜的核心细胞,在所有三种非特异性防御模式中发挥作用,也受到特异性免疫机制的增强。巨噬细胞功能和生理的改变可能对确定肺部防御的有效性至关重要。肺泡巨噬细胞细胞生物学的最新进展使人们对其复杂功能有了更深入的了解。巨噬细胞来自局部和循环细胞池的多种起源以及它们命运和寿命的变异性反映了这种细胞类型的多方面作用。巨噬细胞与其他肺细胞及其他防御机制之间相互作用的重要性日益明显。除了作为肺泡的常驻防御者发挥作用外,巨噬细胞还是肺部免疫反应的重要效应器,在多种炎症性、破坏性和纤维化肺部疾病的发病机制中起关键作用。体液免疫和细胞介导的免疫反应增强并指导肺部对感染的防御,也可能参与对其他病原体的防护。免疫球蛋白A和G、微生物中和及调理抗体以及刺激巨噬细胞的T淋巴细胞是肺部防御的主要免疫特异性形式。感染因子、香烟烟雾、空气污染物、工业粉尘以及一系列并存的疾病状态可能损害肺部防御机制,增加对急性和慢性呼吸道疾病的易感性。深入了解肺部保护自身免受传染性、毒性和免疫原性物质日常侵袭的方式,应有助于更好地理解肺部疾病的发病机制和后果,并为呼吸系统疾病患者提供更好的临床护理。